You are here

Article info

Article menu

Download PDFPDF

Correspondence
Riociguat in systemic sclerosis: a potential for disease modification
Free

Authors

  • Siddharth Jain Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India PubMed articlesGoogle scholar articles
  • Varun Dhir Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Varun Dhir, Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India; varundhir{at}gmail.com
View Full Text

Citation

Jain S, Dhir V
Riociguat in systemic sclerosis: a potential for disease modification
Annals of the Rheumatic Diseases 2022;81:e116.

Publication history

  • Received June 1, 2020
  • Accepted June 2, 2020
  • First published July 15, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.